Prevalence and predictors of poor antihypertensive medication adherence in an urban health clinic setting [0.03%]
城市医疗诊所环境中的降压药不良依从性的流行率及影响因素
Amanda D Hyre,Marie A Krousel-Wood,Paul Muntner et al.
Amanda D Hyre et al.
Poor medication adherence may contribute to low hypertension control rates. In 2005, 295 hypertensive patients who reported taking antihypertensive medication were administered a telephone questionnaire including an 8-item scale assessing m...
Randomized Controlled Trial
Journal of clinical hypertension (Greenwich, Conn.). 2007 Mar;9(3):179-86. DOI:10.1111/j.1524-6175.2007.06372.x 2007
Morning hypertension [0.03%]
清晨高血压
Thomas G Pickering
Thomas G Pickering
Alan B Weder
Alan B Weder
Although it has long been appreciated that there is a genetic component to hypertension, it is only recently that specific genes are being identified. This progress is part of a general advancement of our understanding of common, geneticall...
The nonpharmacologic treatment of hypertension: how effective is it? An update [0.03%]
高血压的非药物治疗：其疗效如何？最新研究进展
Marvin Moser,Stanley S Franklin,Joel Handler
Marvin Moser
Following a hypertension symposium in Los Angeles, CA, in October 2006, a panel was convened to update information about lifestyle changes or the nonpharmacologic treatment of hypertension. Dr Marvin Moser, Clinical Professor of Medicine at...
Shahzad Shafique,Aldo J Peixoto
Shahzad Shafique
Atherosclerotic renal artery stenosis is the most common disease of the renal arteries and may lead to ischemic renal disease and hypertension. A close relationship exists between renal and cardiovascular disease, as they often occur concom...
Microalbuminuria: what is it? Why is it important? What should be done about it? An update [0.03%]
微量白蛋白尿：是什么？为什么重要？应该怎么做？最新观点
Atul Chugh,George L Bakris
Atul Chugh
Microalbuminuria (MA) is defined as a persistent elevation of albumin in the urine of >30 to 20 to 300 mg/d. Data support the concept that the presence of MA is the kidney's warning that there is a problem with the vasculature. The presence...
Comparison of increasing doses of olmesartan medoxomil, losartan potassium, and valsartan in patients with essential hypertension [0.03%]
不同剂量的奥美沙坦酯、氯沙坦钾和缬沙坦治疗原发性高血压患者的对比研究
Thomas D Giles,Suzanne Oparil,Tonous N Silfani et al.
Thomas D Giles et al.
This 12-week, randomized, double-blind, forced-titration study compared the efficacy of 3 angiotensin receptor blockers. Patients received olmesartan medoxomil 20 mg, losartan potassium 50 mg, valsartan 80 mg, or placebo once daily. At week...
Randomized Controlled Trial
Journal of clinical hypertension (Greenwich, Conn.). 2007 Mar;9(3):187-95. DOI:10.1111/j.1524-6175.2007.06395.x 2007
Effects of valsartan or amlodipine alone or in combination on plasma catecholamine levels at rest and during standing in hypertensive patients [0.03%]
缬沙坦或氨氯地平单用或联用对高血压患者卧位和直立时血浆儿茶酚胺水平的影响
Jacques de Champlain,Maria Karas,Linda Assouline et al.
Jacques de Champlain et al.
To compare the effects of valsartan and amlodipine alone or in combination on plasma norepinephrine (NE) at rest and standing for 10 minutes in patients with hypertension, 47 patients with a sitting diastolic blood pressure (BP) (DBP)>95 mm...
Randomized Controlled Trial
Journal of clinical hypertension (Greenwich, Conn.). 2007 Mar;9(3):168-78. DOI:10.1111/j.1524-6175.2007.05938.x 2007
Keith C Ferdinand
Keith C Ferdinand
Hypertension prevalence increases and hypertension control rates improve in the United States: 2003-2004 [0.03%]
美国的高血压患病率上升且高血压的控制情况在改善：2003-2004年数据
Michael J Bloch,Jan Basile
Michael J Bloch